Stocks and Investing Stocks and Investing
Thu, May 11, 2023

Samantha Semenkow Maintained (BEAM) at Strong Buy with Decreased Target to $60 on, May 11th, 2023


Published on 2024-10-28 03:42:43 - WOPRAI, Samantha Semenkow
  Print publication without navigation


Samantha Semenkow of Citigroup, Maintained "Beam Therapeutics Inc." (BEAM) at Strong Buy with Decreased Target from $62 to $60 on, May 11th, 2023.

Samantha has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 1 agrees with Samantha's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • William Pickering of "Bernstein" Initiated at Hold and Held Target at $37 on, Tuesday, March 21st, 2023


These are the ratings of the 3 analyists that currently disagree with Samantha


  • Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $105 on, Wednesday, March 1st, 2023
  • Rick Bienkowski of "Cantor Fitzgerald" Initiated at Buy and Held Target at $62 on, Wednesday, February 1st, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $77 on, Monday, January 23rd, 2023
Contributing Sources